To access the Chinese market with a medical device, you must acquire the Medical Device Registration Certificate from the National Medical Product Administration (NMPA). In case you do not have a subsidiary in China, you have to appoint a local legal agent and service agent to deal with registration and after-sales service.
We help foreign medical device manufacturers to find suitable local distributors in China through a practical approach. Through extensive international and local networking, we can help to pool, short-list potential distributors, and to assist you to expand or change the existing distribution network.
How Qserve can be your China agent
Clinical Situation China
For the registration file in China, one of the required documents is Clinical Evaluations. Although you should have this document for your EU and US registrations, the requirements in China are slightly different. China positions the clinical safety in between the requirements of the EU (Notified Bodies) and the US (FDA). The new acceptance criteria on clinical data are published since early 2018, while the new clinical requirements have been updated in 2021.
China regulations have been dynamically changed. One of the impacts is that the China Health Authority has increased the overseas manufacturing site inspection. These are audits comparable to MDSAP, Notified Bodies and US FDA. It is a potential risk to the foreign manufacturers if they are not awaring of the gaps between China requirements and their own countries. Major non-conformity notice may lead to certificate suspension/cancellation. Mock-audits and trainings to get prepared for the China Health Authority inspection teams are important factors to consider for internal QMS management.
Did you check your China compliance?
Or do you want to know all these impacts on your company? We provide a free compliance check.
China Compliance check